Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001423029-25-000007

Chief Executive Officer sold 26,031 shares at an average $68.04 ($1,771,022)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-19 Sale : show line 1 in the form 10b5-1 −3,979 $66.67 $265,280 3,827,978 D
2025-12-19 Sale : show line 2 in the form 10b5-1 −8,147 $68.01 $554,077 3,819,831 D
2025-12-19 Sale : show line 3 in the form 10b5-1 −1,319 $68.48 $90,325 3,818,512 D
2025-12-22 Sale : show line 4 in the form 10b5-1 −10,012 $68.33 $684,120 3,808,500 D
2025-12-22 Sale : show line 5 in the form 10b5-1 −2,574 $68.85 $177,220 3,805,926 D
Open-market sales · 26,031 sh · avg $68.04 · $1,771,022
Loading xslF345X05/wk-form4_1766530888.xml…